Intellectual Property Portfolio

Prosensa has an active IP strategy, whereby it carefully protects its interests. The company has ensured a good level of IP protection for its lead products in DMD in both Europe and the US with both issued claims in Europe (DMD exon claims) and the US (composition of matter PRO051/GSK2402968) and pending claims in both Europe and the US.

In addition, Prosensa has developed or licensed a broad set of patent families covering pipeline products and discovery projects. This position will further be strengthened by an active in-licensing strategy through its strong academic network.